INTRODUCTION
Papillary thyroid carcinoma (PTC) is the predominant type of thyroid cancers and develops in the follicular cells of the thyroid. It is the most rapidly increasing cancer, probably because of the increased detection of small, low-risk PTC. The incidence of PTC rapidly increases in worldwide during the past 10 to 20 years. According to the data from the National Cancer Center in Korea (http:// www.cancer.go.kr), among adolescents and adults be-tween ages 15 years and 64 years, thyroid cancer is the first most common cancer, and PTCs are the most common of all thyroid cancers. Most PTC patients with thyroidectomy following the treatments of thyroid hormone suppression and radioactive iodine ablation have a good prognosis. However, PTC recurs in some patients and is the major one of endocrine cancer deaths [1, 2] . To date, the tailored target therapies for the patients who fail to respond to the initial treatment paradigm and who have the progressive and refractory cancers are being investigated.
Environmental factors such as radiation, hormones, diet, and smoking are risk factors of PTC, and genetic factor has also implicated as a risk factor for the development and progression of PTC [3] [4] [5] .
The extracellular matrix (ECM) (i.e., thrombospondin 1 The ECM-CAM interactions also affect in the tumor microenvironments such as tumor cell adhesion, proliferation, migration, invasion, and metastasis [10] [11] [12] . Integrins are transmembrane proteins and compose of an alpha chain and a beta chain. Integrin, alpha 6 (ITGA6) is a member of ECM adhesion receptor, and interacts beta chains, making the heterodimeric complexes consisting of one alpha chain and one beta chain (α6β1 and α6β4) [9, 13] . Both α6β1 and α6β4 may play critical roles in the progression of cancers and be involved in the initial formation of cancerous tumors. Abnormal expression of α6β4 in the suprabasal cell layers has been associated with an increased malignancy of squamous cell carcinomas [10] [11] [12] . Integrins participate in cellular signalings such as the mitogen-activated protein kinase (MAPK)/nuclear factor of kappa light polypeptide gene enhancer in B-cells (NFKB), phosphoinositide-3-kinase (PI3) kinase/v-akt murine thymoma viral oncogene homolog (AKT), and mothers against decapentaplegic homolog (SMAD) signalings [14] [15] [16] . In particular, α6β1 directly bind THBS1 in thyroid cancer cells and this complex then activates the MAPK signaling. These actions may remodel the ECM microenvironments and elicit tumor cell invasion into the lymph node and other tissues from the basement membrane, causing the progression of thyroid cancer [17] . Although integrins may be involved in PTC susceptibility, the genetic determinants have not yet been fully defined.
In this study, we explored the relationship between ITGA6 SNPs and PTC, and their clinicopathologic characteristics in Korean population.
METHODS
We enrolled 104 PTC patients (29 males and 75 females) and 318 control subjects (105 males and 213 females). PTC patients were selected among participants who visit at the The data was also analyzed using SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA). The statistical significance level was set at P ＜ 0.05. Table 1 shows the demographic and clinicopathologic features of PTC patients and control subjects. The age of PTC patients and control subjects was 53.2 ± 11.9 (mean ± SD) and 57.9 ± 12.1 years, respectively. In the subgroups of PTC, the number of PTC patients with cancer size ≥1 cm and ＜1 cm was 51 (50%) and 51 (50%), respectively. P-value means significance association. P-value means significance association. P-value means significance association. gene may be associated with the development of PTC, but rs2141698 not, and the A allele of rs11895564 might be a risk factor of PTC. All PTC patients were divided into subgroups according to the clinicopathologic characteristics.
RESULTS
As shown in Table 3 In Table 4 , the rs11895564 SNP had significant differences between PTC patients with unifocality and PTC patients multifocality (P = 0.034; OR, 2.77; 95% CI, 1.08 to 7.11 in dominant model; P = 0.015; OR, 2.86; 95% CI, 1.20 to 6.81 in log-additive model). The A allele distribution of rs-11895564 in the multifocality group (20.8%) was about 2.4-fold higher, compared to the unifocality group (8.5%).
These data suggest that ITGA6 rs11895564 may be involved in the multifocality of PTC. In addition, rs11895564
was associated with the lymph node metastasis of PTC in only overdominant model (P = 0.029; OR, 0.27; 95% CI, 0.07 to 0.99) ( Table 5 ). The rs2141698 and rs11895564 were not contributed to the location and extrathyroidal invasion of PTC, respectively (data not shown). We did not evaluate on the angiolymphatic invasion of PTC, because the number of patients with angiolymphatic invasion was little (n = 6). Haploview ver. P-value means significance association. 
DISCUSSION
This study is first on the genetic relationships between ITGA6 SNPs and PTC in the Korean population. We analyzed the promoter SNP (rs2141698, -1687A/G) and missense SNP (rs11895564, Ala380Thr) in PTC patients and control subjects. We also investigated the association between two SNPs and the clinicopathologic characteristics of PTC. Our results revealed that a missense SNP (rs11895564) was associated with the development of PTC (P = 0.018 in codominant1, P = 0.011 in dominant, P = 0.024 in overdominant, and P = 0.007 in log-additive models; P = 0.005 in allele distributions). In recent, several researchers have reported the relationship between PTC and candidate genes including vascular endothelial growth factor A (VEGFA) [18] , protein tyrosine phosphatase, receptor type, J (PTPRJ) [19] , interleukin 6 (interferon, beta 2) (IL6) [20] , IL10 [21] , and collagen type XI α1 (COLIIAI) [22] . To our knowledge, there is no study that investigated for the association between ITGA6 and PTC. Only two studies were reported on the association between ITGA6 and cancers.
Johnatty et al. [23] reported that an intron SNP (iSNP) rs13027811 of ITGA6 was related to ovarian cancer. The study by Cheng et al. [24] showed that the rs12621278 iSNP of ITGA6 was strongly associated with the progression of prostate cancer. Like above mentioned two literatures, our results showed that a missense rs11895564 SNP was associated with PTC. It is well-known that poor prognostic factors of PTC are thought to be large size, multifocality, multicentricity, extrathyroidal invasion, lymph node metastasis, age (＞50 years), male, and high histologic grade [25] [26] [27] [28] . When the maximum diameter of PTC is lesser 1 cm, papillary thyroid microcarcinoma (PTMC)
is defined by the World Health Organization. PTMC generally appears good prognosis and therefore tend to have a less aggressive treatment, compared to conventional PTC. In contrast, some researchers have shown that the clinical feature of PTMC is similar pattern to PTC and they propose PTMC should be managed like the treatment of PTC [29, 30] . In this study, the associations between a missense SNP (rs11895564) and the clinicopathologic characteristics of PTC were found. The rs11895564 SNP was associated with the size of cancer (＜1 cm vs. ≥1 cm) (P = 0.028 in codominant1, P = 0.016 in dominant, P = 0.040 in overdominant, and P = 0.010 in log-additive models; P = 0.010 in allele distributions), the number of cancer (unifocality vs. multifocality) (P = 0.034 in dominant and P = 0.015 in log-additive models; P = 0.015 in allele distributions), and were associated with progression of cancers [31] [32] [33] [34] [35] . Chen et al. [34] reported that variant allele of rs1051730 in CHRNA3 gene was associated with larger tumor size at diagnosis of squamous cell carcinoma. They suggested that lung tumorigenesis may be driven not only by somatic mutations caused by tobacco carcinogens but also certain polymorphisms that may bring about physiological change. In present study, our results suggest one possibility that the SNP of ITGA6 may be a risk factor of PTC, and also contribute to the progression of PTC.
Our study has several limitations. Firstly, sample size is small. Secondly, controls did not examine thyroid ultrasonography for the detection of potential thyroid cancers.
Thirdly, the follow-up study was not performed. Another limitation is that the multi-variate analysis and other risk factors including age, and gender were not conducted. For the exact correlation between IGTA6 and PTC, additional studies with larger sample size and based on the multivariate analysis could be needed.
In conclusion, our data suggest that a missense SNP (rs11895564, Ala380Thr) of the ITGA6 gene may be associated with the development of PTC and could be a useful marker for the cliniopathologic characteristics such as the size, number, and lymph node metastasis of PTC in Korean population.
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